跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,190 条关于
“KRAS-mutant tumors”
全部
26,190
临床试验
19,397
药物
771
机构
62
资讯
5,960
去年
Amgen Develops Pan-KRAS Inhibitor AMG 410 to Target Broader Range of KRAS-Mutant Tumors
10个月前
Kazakhstan's Anti-Cancer Drug Targeting KRAS-Mutant Tumors Advances to Phase 2026 Clinical Trials
3天前
FDA Grants Fast Track Designation to Kestrel's Oral Pan-KRAS Inhibitor KST-6051 for KRAS-Mutant Solid Tumors
去年
Elicio Therapeutics Advances mKRAS-Targeting Cancer Vaccine, Anticipates Phase 2 Results in H1 2025
6个月前
Sino Biopharmaceutical Receives NMPA Approval for Pan-KRAS Inhibitor TQB3205 Clinical Trial
5个月前
Champions Oncology to Present Eight Studies on Predicting Cancer Drug Response at AACR 2026
8个月前
Merck Launches Phase 3 KANDLELIT-007 Trial for Calderasib-KEYTRUDA QLEX Combination in KRAS G12C-Mutant Lung Cancer
6个月前
Kestrel Therapeutics Receives FDA Clearance for Pan-KRAS Inhibitor KST-6051 Phase 1 Trial
去年
Alterome Therapeutics Initiates Phase 1 Trial of Novel Pan-KRAS Inhibitor ALTA3263 for Advanced Solid Tumors
去年
InxMed Reports Breakthrough Results for Ifebemtinib-Garsorasib Combination in KRAS G12C-Mutant Cancers at ASCO 2025
第 1 页,共 596 页
上一页
下一页